The stances below are c8alpha's editorial distillation of David Giroux's public commentary — television, podcasts, and interviews — compiled by automated transcript analysis and dated to the episode they came from. They may lag the speaker's current view and may contain extraction errors. Text in quotation marks is verbatim from the episode; everything else is our paraphrase. David Giroux is not affiliated with c8alpha and has not endorsed this page. Nothing here is investment advice.
Raw direction-aware returns on public statements — long calls credited when the price rose, shorts when it fell, shorts capped at −100% — in a rising market this mostly measures who was long, not who has skill. Returns run from the stance date; calls are rarely closed publicly, so fixed 90-day / 180-day / 1-year horizons are used. A horizon shows only once it has fully matured, and only at 5+ scored stances.
2025-02-07
ROP
bullish
The Compound · video
Roper Technologies is a collection of niche software businesses compounding earnings at a low double-digit rate; reclassified into the software sector after divesting industrials and priced at roughly 20x free cash flow, making it an under-owned compounder…
“it's a company that will compound earnings at a low double digit rate”
90d +0.5% · 180d -5.1% · 1y -38.2%
Stock Shortage | TCAF 177
2025-02-07
AMZN
bullish
The Compound · video
Amazon is projected to deliver the second-highest earnings growth (~77%) among the large-cap 75 this year as its profitability finally re-accelerates after a post-pandemic overspend cycle, with Andy Jassy gaining credibility as a capital allocator
“I think Jassy now is getting into that place where he's like — people are starting to venerate his abilities finally”
90d -16.2% · 180d -3.0% · 1y -8.9%
Stock Shortage | TCAF 177
2025-02-07
SPX
bearish
The Compound · video
Company-by-company 5-year DCF analysis targeting 2030 prices yields a forward total return below 5% annually, as the index trades at 22x 2025E earnings and 26x free cash flow with minimal margin for disappointment in an extrapolating market
“I don't mean to start this conversation on a down note, but we are probably as negative about the S&P 500 as we have been in a long time”
90d +5.7% · 180d -6.0% · 1y -16.9%
Stock Shortage | TCAF 177
2025-02-07
RVTY
bullish
The Compound · video
Revvity shed its industrial businesses to become a pure software/reagent/immunodiagnostics play with 75% of profits in high-single to low-double-digit growth segments, margins at 28-29% that should reach 35%, active buybacks, and a royalty optionality layer —…
“I think this is a $300 stock”
90d -21.8% · 180d -27.6% · 1y -13.2%
Stock Shortage | TCAF 177
2025-02-07
High Yield
bearish
The Compound · video
Leveraged loans sit at the top of the capital structure and are floating-rate, so they benefit when rates stay higher while high-yield and investment-grade bonds face spread-widening risk in the same scenario — the one fixed-income asset that does not lose…
“they're the one thing in fixed income when rates go higher — floating rate”
90d +0.4% · 180d +4.2% · 1y +8.1%
Stock Shortage | TCAF 177
2025-02-07
BANKS
bearish
The Compound · video
Cyclical financials are trading at 17x earnings versus a 10-year norm of 12-13x, effectively pricing in peak net interest margins and peak earnings simultaneously, creating a setup where you are putting a peak multiple on peak numbers
“you have a weird situation with the banks — you're kind of putting a peak multiple on peak earnings”
90d +10.1% · 180d +4.2% · 1y -16.5%
Stock Shortage | TCAF 177
2025-02-07
SOFTWARE COMPANIES (AI COST AND REVENUE BENEFICIARIES)
bullish
The Compound · video
Software companies are the clearest AI winners because they can both accelerate revenue growth by embedding AI features that clients will pay for, and structurally lower their own cost base as the cost of writing code falls — margins should expand from both…
“not only do they potentially have revenue growth acceleration... but their cost structure can go lower over time”
Stock Shortage | TCAF 177
2025-02-07
HEALTHCARE SECTOR
bullish
The Compound · video
In a richly priced market where financials trade at two times book and consumer discretionary at 49x, healthcare offers defensive earnings plus specific sub-segments — life science tools, managed care — that are not picked over and can re-rate from depressed…
“maybe not everything in healthcare is not picked over”
Stock Shortage | TCAF 177